Technical Analysis for TYP - Tryptamine Therapeutics Limited

Grade Last Price % Change Price Change
F 0.018 5.88% 0.001
TYP closed up 5.88 percent on Thursday, October 3, 2024, on 50 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Stochastic Buy Signal Bullish 0.00%
Wide Range Bar Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 5.88%
Reversal New Lows Setup Bearish Swing Setup 5.88%
Stochastic Buy Signal Bullish 5.88%
Doji - Bearish? Reversal 5.88%
Doji - Bullish? Reversal 5.88%
New 52 Week Low Weakness 5.88%

   Recent Intraday Alerts

Alert Time
20 DMA Resistance about 14 hours ago
10 DMA Resistance about 14 hours ago
Up 10% about 16 hours ago
Lower Bollinger Band Support about 16 hours ago
Rose Above Previous Day's High about 16 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Tryp Therapeutics Inc., a clinical-stage pharmaceutical development company, focuses on developing psilocybin-related molecules in Canada and the United States. Its lead program candidate TRP-8803, a proprietary formulation of IV-infused psilocin that completed Phase 2a clinical trial for the treatment of binge eating disorder, fibromyalgia, abdominal pain, and visceral tenderness. The company's program candidate TRP-8802, a synthetic and oral psilocybin for the treatment of binge eating, chronic pain, and other indications. The company was formerly known as Artos Pharma Corp. and changed its name to Tryp Therapeutics Inc. in June 2020. Tryp Therapeutics Inc. was incorporated in 2019 and is based in Kelowna, Canada.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Development

Is TYP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.025
52 Week Low 0.017
Average Volume 1,455,697
200-Day Moving Average 0.000
50-Day Moving Average 0.020
20-Day Moving Average 0.019
10-Day Moving Average 0.018
Average True Range 0.001
RSI (14) 52.61
ADX 10.28
+DI 30.233
-DI 30.233
Chandelier Exit (Long, 3 ATRs) 0.017
Chandelier Exit (Short, 3 ATRs) 0.020
Upper Bollinger Bands 0.020
Lower Bollinger Band 0.017
Percent B (%b) 0.34
BandWidth 17.297
MACD Line -0.001
MACD Signal Line 0.000
MACD Histogram -0.0001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.021
Resistance 3 (R3) 0.021 0.020 0.021
Resistance 2 (R2) 0.020 0.019 0.020 0.020
Resistance 1 (R1) 0.019 0.019 0.020 0.019 0.020
Pivot Point 0.018 0.018 0.018 0.018 0.018
Support 1 (S1) 0.017 0.017 0.018 0.017 0.016
Support 2 (S2) 0.016 0.017 0.016 0.016
Support 3 (S3) 0.015 0.016 0.016
Support 4 (S4) 0.015